Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00105729 · ClinicalTrials.gov registry record · NA

Substance Abuse Self-Help Group Referral: Outcomes and Services Use

A NA study of Substance Use Disorders, sponsored by US Department of Veterans Affairs.

Completed
Registry status
NA
Development phase
345
Enrollment target
1
Study location

NCT00105729 is a NA study of Substance Use Disorders that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 345 participants, below the 496-participant average among 93 other Substance Use Disorders trials with a reported enrollment target (30% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00105729, a NA study of Substance Use Disorders, has completed, sponsored by US Department of Veterans Affairs.

COMPLETED
Registry status
NA
Development phase
345 participants
Enrollment target
1
Study location

Study Summary

Self-help groups (SHGs) have become an important component of the system of care for patients with substance use disorders (SUDs). SUD patients' participation in SHGs has been linked to lower relapse rates and less use of additional treatment services.

Conditions Studied

Interventions

  • BEHAVIORAL Intensive referral to 12-step self-help groups

Study Locations (1)

California

  • VA Palo Alto Health Care System, Palo Alto, CA - Palo Alto

Trial Details

FieldValue
Enrollment Target 345 participants
Start Date 2003-01
Est. Completion 2005-04
Phase NA

Sponsor

US Department of Veterans Affairs

632 total trials

What the Registry Record Tells You About NCT00105729

The ClinicalTrials.gov registry entry for NCT00105729 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 345 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 496-participant average among 93 other Substance Use Disorders trials with a reported enrollment target (30% lower). The listed sponsor is US Department of Veterans Affairs, which has 632 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Substance Use Disorders appearing as the primary indexed condition, and to 1 intervention - of which Intensive referral to 12-step self-help groups is the first listed.

NCT00105729 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT00105729 about?

NCT00105729 is a clinical study titled "Substance Abuse Self-Help Group Referral: Outcomes and Services Use". Self-help groups (SHGs) have become an important component of the system of care for patients with substance use disorders (SUDs). SUD patients' participation in SHGs has been linked to lower relapse rates and less use of additional treatment services.

What is the current status of trial NCT00105729?

This trial is currently completed. It is a NA study. The enrollment target is 345 participants. The study started on 2003-01. Estimated completion is 2005-04.

What conditions does trial NCT00105729 study?

This clinical trial studies the following conditions: Substance Use Disorders.

What interventions are being tested in trial NCT00105729?

The interventions under investigation include: Intensive referral to 12-step self-help groups (BEHAVIORAL).

Who is sponsoring clinical trial NCT00105729?

This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00105729 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Substance Use Disorders

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.